0001567619-19-006066.txt : 20190304 0001567619-19-006066.hdr.sgml : 20190304 20190304183936 ACCESSION NUMBER: 0001567619-19-006066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190304 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdun-Nabi Daniel CENTRAL INDEX KEY: 0001380187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 19655869 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DRIVE STREET 2: SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2019-03-04 0 0001367644 Emergent BioSolutions Inc. EBS 0001380187 Abdun-Nabi Daniel 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 1 0 0 CEO Common Stock 2019-03-04 4 S 0 14565 58.1070 D 142617 D Common Stock 1936 I By Son The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. The price reported is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.74 to $59.66, inclusive. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ S. Scott Lieberman, Attorney-in-fact 2019-03-04